๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Atorvastatin and celecoxib: A future role in cancer chemoprevention

โœ Scribed by Shailendra Kapoor

Book ID
102274995
Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
32 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Progress in Cancer Chemoprevention
Progress in Cancer Chemoprevention
โœ GARY J. KELLOFF; JAMES A. CROWELL; VERNON E. STEELE; RONALD A. LUBET; CHARLES W. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 227 KB
Chemoprevention in prostate cancer: The
Chemoprevention in prostate cancer: The role of difluoromethylornithine (DFMO)
โœ Dov Kadmon ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 511 KB

The polyamines are normal cell constituents considered to have an important role in the regulation of proliferation and differentiation. DFMO is an irreversible, enzyme-activated, suicide inhibitor of ornithine decarboxylase (ODC), the enzyme responsible forthe first and rate-limiting step in mammal

The role of prostate-specific antigen in
The role of prostate-specific antigen in the chemoprevention of prostate cancer
โœ E. David Crawford; Edward P. DeAntoni; Colleen A. Ross ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 691 KB

An understanding of the natural history of changes in prostate-specific antigen (PSA) may be valuable as a surrogate view of prostate dynamics, as a method to differentiate between benign and malignant growth, and as a means to assess the use of PSA as a tool for monitoring activity of chemopreventi